Skip to main content
  • Liver cancer therapies

Liver Cancer Therapies Virtual Conference

Who Should Attend

This meeting will be of interest to Surgeons, Hepatologists, Oncologists, Interventional Radiologists, Gastoenterologists, Nurses, Nurse Practitioners, Physician Assistants, Residents, Fellows, and Medical Students.

Learning Objectives

  1. Discuss the scope of liver cancer program at UMMC and affiliated hospitals.
  2. Describe key directions in current liver cancer research.
  3. Identify new directions in treatments for liver cancer.

Accreditation and Credit Designation

The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit.™

CME Questions

Gloria Owens
Academic Services Specialist
Office of Faculty Affairs and Professional Development
410-706-3103 fax

December 9, 2022
9 AM - 5 PM | Virtual

Register Online

Conference Co-Directors

Kevin KimKevin Kim, MD, MHS

Professor, Department of Diagnostic Radiology & Nuclear Medicine
Chief, Division of Vascular & Interventional Radiology, UMGCCC

Dr. Kim's Faculty Profile

Daniel MalufDaniel G. Maluf, MD

Professor, Department of Surgery
Director, Program in Transplantation

Dr. Maluf's Faculty Profile

Conference Chair

Kevin CullenKevin J. Cullen, MD

Professor, Department of Medicine
Director, Program in Oncology
Director, UMGCCC

Dr. Cullen's Faculty Profile

Presented By:

Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC)

University of Maryland Transplant Center